| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Outline of Final Research Achievements |
In Japan, as the aging society, medical treatment and care at the end of life have become an important problem, and the problems of euthanasia, death with dignity and the termination of treatment are also becoming more important. Japanese precedents have allowed positive euthanasia, but there have been no cases actually recognized. Though the supreme court has admitted the termination of treatment at the end of life, detail is left to future guidelines or legislation. Countries legalizing the medical assistance in dying have been increasing, most recently, several states of the United States, Canada, Victoria state of Australia. In Japan, there is little possibility that the medical assistance in dying will be legalized in the near future. However, when such legislation is considered, these comparative law knowledge will be useful. In particular, the Canadian example contains important suggestions for the cooperation between judiciary and legislator.
|
